• Mechanisms of Cell Death in Heart Disease

  2026-09-03

  Konstantinidis, Whelan, and Kitsis synthesize evidence that cardiac injury involves not only apoptosis but also actively regulated forms of necrosis, with overlapping signaling through death receptors, mitochondria, and the endoplasmic reticulum. The review provides a conceptual framework for interpreting cell-death phenotypes and for evaluating small-molecule interventions, while also clarifying why later ferroptosis assays require distinct biochemical validation.

• SIS3: A Causal Tool for Smad3 Biology

  2026-09-03

  SIS3 is a selective Smad3 inhibitor for resolving TGF-β signaling rather than merely measuring pathway activity. This article translates evidence from osteoarthritis, fibrosis, renal, and diabetic nephropathy models into practical experimental design and interpretation guidance.

• 5-Methyl-CTP Workflow for Stable mRNA

  2026-09-02

  A practical guide to using 5-Methyl-CTP in in vitro transcription, from nucleotide-pool design and RNA quality control to reporter assays and vaccine-oriented workflows. It also translates an OMV-based mRNA delivery study into assay choices while separating demonstrated findings from optimization hypotheses.

• HCMV, UL38, and AKT Inactivation

  2026-09-02

  The reference study identifies an HCMV-driven mechanism in which the viral protein UL38 activates mTORC1, destabilizes IRS1, and prevents stimulus-dependent AKT membrane recruitment. This work links viral control of host metabolism and protein phosphorylation signaling to a cell-intrinsic negative feedback loop with implications for infection biology and phosphoproteomic experimental design.

• Etoposide (VP-16) DNA Damage Assay Workflow

  2026-09-01

  Etoposide (VP-16) provides a practical way to connect topoisomerase II inhibition with DNA double-strand break and apoptosis measurements. This workflow emphasizes cell-line calibration, solvent control, orthogonal readouts, and a senescence-aware interpretation strategy for cancer chemotherapy research.

• A 83-01: Practical ALK-5 Inhibitor Workflows

  2026-09-01

  A 83-01 provides a practical way to interrogate TGF-β-dependent transcription, EMT, and growth responses in conventional cells and hiPSC-derived intestinal models. This guide connects pathway inhibition with organoid pharmacokinetic workflows while emphasizing dose selection, controls, and troubleshooting.

• Why In Vitro Cancer Drug Responses Need Two Metrics

  2026-08-31

  Hannah Schwartz’s dissertation separates proliferative arrest from cell killing, showing that conventional relative viability can obscure how anticancer drugs act over time. This framework supports more precise assay design and interpretation when comparing compounds, models, and response mechanisms.

• AZD1390: ATM Kinase Inhibitor Workflow

  2026-08-31

  Build mechanism-led radiation and replication-stress assays with AZD1390, linking ATM pathway suppression to double-strand-break signaling and G-quadruplex tolerance. The workflow emphasizes concentration control, model selection, orthogonal readouts, and troubleshooting for glioma, lung cancer, and broader cancer research.

• Direct Mouse Genotyping Kit for STING Models

  2026-08-30

  The Direct Mouse Genotyping Kit enables purification-free PCR-based mouse genetic screening for mechanistic cholestasis studies. This guide connects rapid allele verification with the STING–cholangiocyte biology reported in a 2026 liver disease study, emphasizing assay controls, cohort traceability, and interpretation limits.

• Phosbind Acrylamide for Translational Signaling

  2026-08-29

  A mechanistic guide to using Phosbind Acrylamide for antibody-independent phosphorylation analysis, with strategic implications for ISR, coronavirus biology, kinase assays, and translational decision-making.

• EGTA for Calcium Signaling: Workflows & Tips

  2026-08-28

  EGTA, or egtazic acid, provides a practical way to lower free calcium without treating every calcium channel as equivalent. This guide translates calcium-chelation principles into workflows for electrophysiology, neuroprotection, endothelial studies, and apoptosis assays, with controls that help separate true signaling effects from pH, solubility, and handling artifacts.

• Spatial Kidney Assembloids for Disease Modeling

  2026-08-28

  Huang and colleagues developed mouse and human kidney progenitor assembloids that organize nephron progenitors around a central collecting system, improving spatial patterning, maturation, and kidney-like function. Their in vivo-grown PKD2−/− human assembloids also reproduced key features of polycystic kidney disease and exposed interactions among cyst epithelium, stroma, and macrophages.

• 3-Hydroxybutyrate (BHBA) in Stroke Assays

  2026-08-27

  3-hydroxybutyrate (BHBA) is more than a ketone fuel: it is a metabolic, ferroptosis-related, membrane, and chromatin-regulatory variable. This article translates stroke research into a rigorous assay framework for distinguishing direct BHBA effects from whole-body ketosis and remote ischemic conditioning.

• Cyclic di-GMP Controls Biofilm Persistence

  2026-08-27

  Liao et al. identify Cyclic di-GMP as a small-molecule antitoxin that restrains the genotoxic toxin HipH during early biofilm development. Their findings connect adhesion-stage signaling with DNA double-strand breaks, genome instability, and antibiotic persistence, providing a mechanistic framework for studying biofilm resilience.

• DAMGO for µ-Opioid Receptor Circuit Studies

  2026-08-26

  Use DAMGO to connect receptor-level activation with brain-to-spinal pain circuitry, from G protein assays to mechanical hypersensitivity models. Its strong MOR selectivity makes it a practical comparator for separating µ-opioid receptor mechanisms from broader opioid effects.

8597 records 1/574 page Next 12345 下5页 Last page